Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3011-3020 Newer>

BusinessWeek July 17, 2006 Bruce Einhorn	A Key New Ally In The Cancer War China and its Western trade partners are fighting together on at least one front: the war on cancer.
The Motley Fool July 6, 2006 Brian Lawler	Cephalon on the Hunt The biopharma company is looking to make more acquisitions and gets some good news from the FDA. Cephalon's stock climbed by more than 10% after the announcement.
The Motley Fool July 5, 2006 Rich Duprey	Flu Vaccine Deja Vu The country's largest vaccine maker, Sanofi Aventis, gets an FDA warning letter reminiscent of the 2004 debacle.
The Motley Fool July 5, 2006 Brian Lawler	Stay Away From QLT Competitive pressure on its top drug makes this company one investors should avoid.
The Motley Fool July 5, 2006 Glenn Brandys	FoxHollow's SilverHawk Won't Soar Cost, time, and competition are holding back the med-tech's device for treating artery disease. Investors, take note.
Pharmaceutical Executive July 1, 2006 Ron Feemster	FDA Raises the Stakes Pfizer was an early adopter of RFID, but CEO Hank McKinnell says a mature track-and-trace system is five years down the road.
Pharmaceutical Executive July 1, 2006 Ron Feemster	Good Counsel Law the Pfizer way: Crack down on counterfeiters, build a private police force, and make nice with the Office of the Inspector General. Then hire a foreign-policy expert.
Pharmaceutical Executive July 1, 2006 Jeannette Park	Roundtable: Are We There Yet? How About Now? Now? Can Electronic Data Capture become the industry standard for clinical trials? In this roundtable discussion, six early adopters reveal where they struggled, and what you need to know to implement this new technology.
Pharmaceutical Executive July 1, 2006 Jill Wechsler	Washington Report: Hard Evidence The push for more useful information on medication effectiveness is shaping drug development and reimbursement.
Pharmaceutical Executive July 1, 2006 Deborah Dunsire	Thoughtleader: Targeted Expansion Millennium Pharmaceuticals' CEO discusses what's ahead for the company, its success through partnerships, and why it believes it can lead the pack in targeted therapeutics.
<Older 3011-3020 Newer> Return to current articles.